Kuyini i-Nitric Oxide?
I-nitric oxide igesi ekhiqizwa amaseli ahilelekile ekuvuvukeni okuhambisana ne-asthma ye-allergy noma ye-eosinophilic.
Kuyini i-FeNO?
Ukuhlolwa kokukhipha umoya kwe-Nitric Oxide (FeNO) okuyingxenye kuyindlela yokulinganisa inani le-nitric oxide emphefumulweni okhishwa umoya. Lokhu kuhlolwa kungasiza ekuxilongweni kwe-asthma ngokukhombisa izinga lokuvuvukala emaphashini.
Ukusetshenziswa Kwezokwelapha kwe-FeNO
I-FeNO inganikeza isithasiselo esingahlaseli sokuxilongwa kokuqala kwe-asthma nge-ATS kanye ne-NICE beyincoma njengengxenye yeziqondiso zabo zamanje kanye nama-algorithms okuxilonga.
| Abantu abadala | Izingane | |
| I-ATS (2011) | Okuphezulu: >50 ppb Okuphakathi: 25-50 ppb Okuphansi:<25 ppb | Okuphezulu: >35 ppb Okuphakathi: 20-35 ppb Okuphansi:<20 ppb |
| I-GINA (2021) | ≥ 20 ppb | |
| I-NICE (2017) | ≥ 40 ppb | >35 ppb |
| Isivumelwano saseScotland (2019) | >40 ppb iziguli ezingakwazi ukufunda i-ICS Iziguli ezingaphezu kuka-25 ze-ppb ezithatha i-ICS |
Izifinyezo: I-ATS, i-American Thoracic Society; i-FeNO, i-nitric oxide ekhishwe kancane kancane; i-GINA, i-Global Initiative for Asthma; i-ICS, i-corticosteroid ephefumulayo; i-NICE, iNational Institute for Health and Care Excellence.
Iziqondiso ze-ATS zichaza amazinga aphezulu, aphakathi, kanye naphansi e-FeNO kubantu abadala njenge->50 ppb, 25 kuya ku-50 ppb, kanye ne-<25 ppb, ngokulandelana. Ngesikhathi kusezinganeni, amazinga aphezulu, aphakathi, kanye naphansi e-FeNO achazwa njenge->35 ppb, 20 kuya ku-35 ppb, kanye ne-<20 ppb (Ithebula 1). I-ATS itusa ukusetshenziswa kwe-FeNO ukusekela ukuxilongwa kwe-asthma lapho kudingeka khona ubufakazi obuqondile, ikakhulukazi ekuxilongweni kokuvuvukala kwe-eosinophilic. I-ATS ichaza ukuthi amazinga aphezulu e-FeNO (>50 ppb kubantu abadala kanye ne->35 ppb ezinganeni), uma ihunyushwa ngokomongo wezokwelapha, ikhombisa ukuthi ukuvuvukala kwe-eosinophilic kukhona nokuphendula kwe-corticosteroid ezigulini ezinezimpawu, kuyilapho amazinga aphansi (<25 ppb kubantu abadala kanye ne-<20 ppb ezinganeni) enza lokhu kungenzeki futhi kuphakathi kwamazinga kufanele kuhunyushwe ngokuqapha.
Iziqondiso zamanje ze-NICE, ezisebenzisa amazinga aphansi e-FeNO cut-off kune-ATS (Ithebula 1), zincoma ukusetshenziswa kwe-FeNO njengengxenye yomsebenzi wokuxilonga lapho kucatshangelwa khona ukuxilongwa kwe-asthma kubantu abadala noma lapho kukhona ukungaqiniseki kokuxilongwa ezinganeni. Amazinga e-FeNO aphinde ahunyushwe ngokomongo wezokwelapha futhi ukuhlolwa okwengeziwe, njengokuhlolwa kokushukunyiswa kwe-bronchial kungasiza ekuxilongweni ngokubonisa ukusabela okukhulu komoya. Iziqondiso ze-GINA ziyaqaphela indima ye-FeNO ekuboneni ukuvuvukala kwe-eosinophilic ku-asthma kodwa okwamanje aziboni indima ye-FeNO kuma-algorithms okuxilonga i-asthma. I-Scottish Consensus ichaza ukunqunywa ngokuya ngokuchayeka kwe-steroid ngamanani amahle angu->40 ppb ezigulini ezingenalwazi lwe-steroid kanye no->25 ppb ezigulini ezisebenzisa i-ICS.
Isikhathi sokuthunyelwe: Mashi-31-2022